Comerica Bank Adaptive Biotechnologies Corp Transaction History

Comerica Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$2.34 - $3.96 $6,832 - $11,563	-2,920 Reduced 99.56%	13 $0
Q1 2024 May 15, 2024	BUY	$2.88 - $4.8 $3,801 - $6,336	1,320 Added 81.84%	2,933 $9,000
Q4 2023 Feb 14, 2024	BUY	$3.46 - $5.33 $3,594 - $5,537	1,039 Added 181.01%	1,613 $7,000
Q3 2023 Nov 21, 2023	BUY	$5.07 - $8.44 $2,910 - $4,844	574 New	574 $3,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

Stay updated on Comerica Bank with notifications on news.